260TiPPhase 3, randomized, double-blind, placebo-controlled study of PEGylated recombinant human hyaluronidase PH20 (PEGPH20)+nab-paclitaxel/gemcitabine in patients with previously untreated, hyaluronan-high, stage IV pancreatic ductal adenocarcinoma (PDA)
Oh, D-Y, Bang, Y-J, Van Cutsem, E, Hendifar, A, Reni, M, Zheng, L, Ducreux, M, Harris, W, Corrie, P, Seery, T, Chondros, D, Bullock, A, Li, C-PVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx660.066
Date:
November, 2017
File:
PDF, 58 KB
english, 2017
File converter
More search results
More benefits 
